Ads
related to: moderna booster
Search results
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 6 hours agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 2 days agoThe booster shot will be available at a clinic from 1 p.m. to 7 p.m. at the Harlingen Health...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 9 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 4 hours agoThe news sent Novavax's stock soaring to more than $23 per share on Thursday morning, but...a strain that Novavax has tested in its lab and is therefore...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 4 hours agoModerna. But the Novavax Covid vaccine has never been officially approved. Instead, the company has...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 1 day agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 2 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 2 days agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...